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Conclusions: 3D tissue culture of expanded human mastoid-
derived periosteal progenitor cells in resorbable PGLA fleeces
initiates bone and cartilage formation on the cellular and molecu-
lar level. The generation of different mesenchymal tissue makes
3D tissue cultured periosteal progenitor cells to promising can-
didates for the treatment of OA. Further investigations with pe-
riosteal progenitor cells from donors with OA were necessary for
an autologous therapy strategy.
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EFFECT OF BLOOD ON THE MORPHOLOGICAL,
BIOCHEMICAL, AND BIOMECHANICAL PROPERTIES OF
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CHONDROCYTES PRE-SEEDED ONTO A BIOLOGICAL
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C. Sosio1, F. Boschetti2, C. Bevilacqua3, L. Mangiavini1,
C. Scotti1, M. Buragas4, G. Fraschini1, A. Gigante3,
G.M. Peretti1
1Hospital San Raffele - Università Vita-Salute, Milan, Italy,
2Laboratory of Biological Structure Mechanics, Politecnico of
Milano, Milano, Italy, 3University of Ancona, Ancona, Italy, 4Yale
University, Yale, CT
Purpose: The use of autologous chondrocytes seeded onto a bi-
ological scaffold represent a current valid tool for cartilage repair.
However, the effect of the contact of the blood to the engineered
construct is unknown. The aim of this work was to investigate the
effect of blood contact on the morphological, biochemical and
biomechanical properties of engineered cartilage.
Methods: Articular chondrocytes were enzymatically isolated
from swine joints, expanded in monolayer culture and seeded
onto collagen membranes for two weeks. Peripheral blood was
obtained from animals of the same spices. The cell-seeded col-
lagen membranes were placed in contact with the blood, diluted
with medium, for three days ("blood" group). As controls ("control"
group), some samples were left in medium, with no blood con-
tact. Some samples were retrieved from cultures after the blood
contact, some others were left in standard culture conditions for
3 more weeks. Samples were analysed grossly, histologically,
biochemically (MTT analysis), and by biomechanical analysis
under unconfined geometry.
Results: Upon retrieval, samples from both groups showed in-
creasing dimensions and weights overtime, with higher mean val-
ues recorded for control group. Biochemical evaluation demon-
strated a transient reduction of the mitochondrial activity due
to blood contact. Histological evaluation demonstrated evident
cartilage-like matrix production for both groups. Biomechanical
data showed a reduction of the values in the early culture time,
followed by a stabilization regardless the presence of the blood.
Conclusions: The results obtained from this study demonstrate
that the contact to blood of the samples determine a transient re-
duction of the mitochondrial activity. However, the morphological
parameters seem to show a continue production of the cartilage
matrix components overtime. This tissue engineered cartilage
structure is easily reproducible and it could represent a valuable
model for studying the behaviour of different variables on the
newly formed cartilage.
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NEW TISSUE GROWTH AFTER COLLAGEN MENISCUS
IMPLANT (CMI) PLACEMENT INCREASES ACTIVITY
LEVELS AFTER TWO YEARS
W.G. Rodkey, K.K. Briggs
Steadman Hawkins Research Foundation, Vail, CO
Purpose: Absence of meniscus tissue leads to decreased clin-
ical function and activity levels. In a previous study, we re-
ported significant correlation between actual measured amounts
of meniscus tissue removed at meniscectomy and symptoms,
function and activity 2 years after surgery. In particular, it was
noteworthy that patients with >50% remaining meniscus tissue
were significantly better in all categories measured than patients
with <50% total meniscus tissue remaining. The purpose of the
present study was to determine, prospectively, changes in Teg-
ner activity levels from preoperative to 2 years postoperative in
patients who received Collagen Meniscus Implants (CMI) and
were documented to have >50% total meniscus tissue at 1-year
relook arthroscopy.
Methods: In a randomized controlled investigational device clin-
ical trial (Level of Evidence I), 138 patients 18 to 60 years old
underwent partial medial meniscectomy and placement of a CMI
to fill the meniscus defect. There were 64 acute (no prior menis-
cus surgery) and 74 chronic (1 to 3 prior partial meniscectomies
on the involved meniscus) patients. At index surgery, meniscus
defect size was measured with specially designed instruments,
and the percent of meniscus loss was calculated based on these
actual measurements. Relook arthroscopy was performed at 1
year on 124 patients (90% surgical follow-up), and percent to-
tal meniscus tissue (remnant + new tissue) was determined by
making these same measurements and calculations. Patients
were followed clinically for a minimum of 2 years after CMI place-
ment. At each follow-up, all patients completed questionnaires,
including a Tegner score to assess activity. We then determined
changes in Tegner score from the index surgery to 2 years status
post CMI in these patients.
Results: Of 124 relooks, 111 patients (90%) had >50% total
meniscus tissue. In these patients, average Tegner activity scores
improved by two levels from 3 to 5 from preoperative to 2
years status post CMI. This increased change in activity levels
significantly correlated with total meniscus tissue >50% (r=0.21,
p=0.02). These findings mirrored those we previously reported
for partial meniscectomy patients in which >50% of the meniscus
was maintained.
Conclusions: There is a significant correlation between change
(increase) in Tegner activity levels over 2 years and percent total
meniscus tissue in patients who receive the CMI as treatment
for meniscus loss and have >50% total meniscus tissue. This
study confirms the importance of preserving as much meniscus
tissue as possible at the time of repair or meniscectomy. It
clearly supports the potential positive benefits of regrowing or
regenerating lost meniscus tissue to assist patients in regaining
their activity.
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Purpose: Osteoarthritis (OA) is such a widespread complication
of old age that it is expected to become the fourth leading
cause of disability by the year 2020. As a hallmark of the
pathogenesis of late stages of the disease, in addition to the
diseased chondrocytes (type 1 cells), type 2 cells emerge. While
S206 Poster Presentations
investigating where these type 2 originate from, we discovered
chondrogenic progenitor cells in OA tissue.
Methods: With the help of cell culture, in situ-hybridization,
immunohistochemistry, Western blot, real time RT-PCR, micro
array and FACS we have characterized the two cell types, as
well as progenitor cells from human OA tissue in vivo and in
vitro.
Results: In vivo, type 1 and type 2 cells show a fibroblast-like
expression pattern with collagen type II and type I synthesis.
Type 2 cells exhibit a faster re-differentiation in 3D alginate cul-
ture. This is indicated by an increased collagen type II expression
already after one week, as well as increased amounts of sox-9. A
subpopulation of type 2 cells also found in OA cartilage consists
of progenitor cells positive for so-called stem cell markers, e.g.
CD105, CD73 or STRO-1 with unregulated PTHrP receptor, up-
regulated RANTES and ADAM-TS5 and lower expression values
for sox-9 than in type 2 cells. Depending on the substrate (colla-
gen, fibronectin or Matrigel) on which they have been grown and
depending on the gender of the patients, these progenitor cells
exhibit a strong interindividual regulation, for example, of colla-
gen type I, fibronectin and integrin alpha 5. In contrast, collagen
type II, sox-9 and COMP remain unregulated. However, they can
be differentiated into osteoblasts, adipocytes and chondrocytes
in vitro.
Conclusions: Due to their OA origin, the type 1 cells remain dis-
eased chondrocytes even without any pathological OA influences
in 3D culture. The re-differentiation efforts of the type 2 cells lead
to a more chondrogenic expression pattern in comparison to their
in vivo status. This shows a more flexible adaptation to changing
environmental conditions and, therefore, they behave more like
progenitor cells.
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OPTIMIZING DIFFERENTIATION PROTOCOL OF HUMAN
MESENCHYMAL STEM CELLS IN SUSPENSION
CULTURE MODEL: DURATION OF CULTURE
CORRELATES WITH EFFECTIVENESS
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Purpose: The prospect of isolating mesenchymal stem cells
(MSC) and culturing these cells into a biomaterial for transplan-
tation into the same patient provides viable option for cartilage
repair. In this study we used our previously described suspen-
sion culture model using poly-HEMA coated plates. We tested
the hypothesis that MSC can differentiate into chondrocytes in
our suspension culture model and that early passage MSCs have
a greater ability to undergo chondrogenesis.
Methods: "Low passage" cells (p3) were isolated and expanded
on adherent flasks for six weeks; "high passage" cells (p9) were
isolated and expanded on adherent 75cm2 flasks for several
months. These cultures were kept in control or chondrogenic
medium (CM). In suspension culture cells self-aggregate. Cells
in each culture type were maintained in DMEM with 10% FBS
or CM (DMEM with 10 μl/mL ITS+premix, 50μg/mL ascorbic
acid, 40μg/mL proline, 10ng/mLTGF-β, and 0.1μM dexametha-
sone). Real-time PCR was performed in triplicate using iQ SYBR
Green, Genes: CD44, collagen types I (CI) and II (CII), aggrecan,
perlecan, decorin, MMP3, MMP13, ADAMTS5, and GAP.
Results: Control biomasses averaged 0.9ug each while those
in CM averaged 7.5ug each. DNA content for the chondrogenic
group was double the control. This suggests that the eight-fold
increase in weight is due more to substantial ECM production
and hydration of ECM components than proliferation. After three
weeks of CM culturing, in suspension culture C II was over 600
fold higher than the control. However, CII expression stayed the
same in suspension cultures after one week of culturing in CM.
Adherent cultures increased in response to ∼70 fold. Western
blot confirmed the presence of CII in the three week cultured
MSCs; the control showed no CII at the protein level. Interestingly,
p9 cells showed a higher CII relative mRNA expression before
the culturing began. These p9 MSCs showed no change in
expression with different culture conditions.
CM decreased CI expression in p3 suspension culture MSCs
but the opposite effect was observed in adherent cultures. CI
was expressed in p9 cells the relative expression did not change
significantly in comparison. CD44 was examined since its expres-
sion can indicate a normal chondrocyte phenotype. P3 adherent
cultured MSCs in CM decreased expression of CD44. However,
CM increased CD44 expression when cultured in suspension
culture. With longer culture time in CM expression of MMP13
becomes much lower as CI and CII expression dramatically in-
creases (in CM). In p3 cells, both aggrecan and ADAMTS-5
expression increases in CM suspension culture at one week
however, when cultured for three weeks, ADAMTS-5 expression
decreases and aggrecan expression remains 5-fold higher than
the control. This supports an initial remodeling of ECM compo-
nents but the overall biosynthesis is towards the formation of
the ECM. Aggrecan is downregulated by CM on adherent plates,
suggesting suspension culture is more conducive to chondroge-
nesis. P9 MSCs do not significantly alter aggrecan or ADAMTS-5
expression with culture or medium
Conclusions: P9 MSC show little ability to alter their phenotype
in comparison to p3 MSCs. Suspension culture initially appears
to inhibit differentiation however this conclusion is misleading and
this culture condition is optimal for the promotion of chondroge-
nesis. It is likely that duration of culture is more important to
see change because of the architectural differences between an
adherent monolayer and a biomass. One week in culture seems
to show the cells in a transitional stage, however longer time in
culture show increased cartilage markers suggesting this may be
a novel approach to engineering cartilage-like material.
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Purpose: Damage to Hyaline cartilage in a large weight bear-
ing joint caused by either trauma or primary focal degenerative
changes (OA), if not treated, can lead to damage of the subchon-
dral bone resulting frequently in pain, disability, and sever altered
quality of life. Since cartilage tissue does not heal spontaneously,
joint functional rehabilitation is based various temporary medical
and surgical solutions. We have developed a novel chondrocytes
cell culture originating from porcine cartilage tissue retrieved
from the mandibular condyle of a newborn animal.
Methods: Porcine Chndrocytes, originating from a mandibular
condyle of a new born animal, are a unique source of cartilage
cells.Gradual collagenase seperation yields a homogenous chon-
drocyte population, which unlike other cartilge source-derived
cells preserve the capability of spontanous differentiation into
cartilage forming cells.
Results: Following a short period of intensive proliferation, these
cells start to differentiate into polygonal shaped cells, expressing
Cbfa1-the skeletal tissues specific transcription factor, type II col-
lagen and cartilage proteoglycan; thus producing ingredients of
genuine hyaline cartilage. The cultured chondrocytes also pre-
serve their responsiveness toward local and systemic regulating
